Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$38.47 0.35 (0.92%)
2/9/2010 4:00 PM

GlaxoSmithKline plc (ADR) (GSK)

CAPS Rating:
*****

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GSK

Add Stock to Watchlist

GlaxoSmithKline plc (ADR) At A Glance

Current Price: $38.47
Last Trade Time: 2/9/2010 4:00 PM
Open: $38.26
Previous Close: $38.12
Daily Range: $37.95 - $38.75
52-Week Range: $27.15 - $43.47
Volume: 3,263,709
Market Cap: $108.90B
P/E Ratio: 9.85
Compare Our Special Broker Offers!

Stock Trends

GSK VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

GlaxoSmithKline plc (ADR) (GSK)

Avatar GreatDana (< 20) Submitted: 12/19/09 2:41 PM

Drugs are good...

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

GlaxoSmithKline plc (ADR) (GSK)

Avatar TyrVsGarm (34.91) Submitted: 7/06/09 2:21 PM

GlaxoSmithKline has two blockbusters coming off patent in 2010 which will affect the bottom line in the near-term. While GSK has a healthy pipeline, it also is sitting on over $10 Billion worth of currency (most of it in dollars). I suspect that it will try to put some (or all) of this cash to wor...More

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 211 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (GSK)

Avatar Tslipknotm (54.91) Submitted: 2/04/10 4:58 PM : Outperform Start Price: $38.62 GSK Score: -0.30

Entire sector will outperform. Dividend.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar tonyrjohnson (29.91) Submitted: 1/28/10 6:53 AM : Outperform Start Price: $40.49 GSK Score: -2.28

undervalued UK big pharma, room for 20% in 12-24 months

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar nrlbuild (92.59) Submitted: 1/15/10 1:46 PM : Outperform Start Price: $40.76 GSK Score: -0.11

I like the 5% dividend in a retirement account. Big pipeline of late stage drugs. Global company based in UK, so some hedge against the dollar. Strong cash flow. Appear to better (more conservative) with picking proper acquisitions than Pfizer. Drug companies are not going away. Recommended by PRO Fools. I do not like the large debt.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar lonewulf47638 (63.75) Submitted: 1/15/10 10:02 AM : Outperform Start Price: $40.89 GSK Score: -0.12

Pays a dividend and has good drug pipe line.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar spotpetes (62.63) Submitted: 1/10/10 4:18 PM : Outperform Start Price: $41.48 GSK Score: -0.43

cheap and decent...

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 211 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackZacks 62.21 01/25/10 Underperform 3M $40.45-4.89%-2.32%+2.57 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer < 20 05/29/09 Underperform 3W $32.91+16.90%+17.09%+0.19
TrackTobinSmith < 20 03/06/09 Outperform 1Y $27.69+38.95%+58.33%-19.38
TrackBillNygren 94.66 06/19/08 Outperform 5Y $40.80-5.72%-17.10%+11.38 Toggle the visibility of 60-Second Pitch and replies
TrackBerkowitz 83.78 05/27/08 Outperform 1Y $40.61-5.27%-19.31%+14.04 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 90.73 09/30/07 Outperform NS $47.61-19.20%-26.38%+7.17 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ < 20 09/30/07 Outperform NS $47.61-19.20%-26.38%+7.17 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $47.61-19.20%-26.38%+7.17 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.91 09/30/07 Outperform NS $47.61-19.20%-26.38%+7.17 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley < 20 09/30/07 Outperform NS $47.61-19.20%-26.38%+7.17 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 84.85 07/25/07 Underperform NS $47.16-18.43%-25.75%-7.32
TrackJPMorgan 84.76 03/22/07 Underperform NS $48.83-21.21%-21.00%+0.21

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 718ms